| Asset | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Equity | 97.06% | 98.78% | 96.61% | 98.03% | 97.41% | 97.26% |
| Debt | 2.78% | 1.02% | 0.98% | 2.55% | 3.65% | 2.88% |
| Others (incl. cash) | 0.16% | 0.20% | 2.41% | -0.58% | -1.06% | -0.14% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 2,30,250 | 41.83 | 8.58% | -0.43%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 80,000 | 38.4 | 7.88% | -0.11%↓ |
| Divis Laboratories Ltd. | Healthcare | 41,000 | 38.1 | 7.82% | -0.19%↓ |
| Ipca Laboratories Ltd. | Healthcare | 1,55,000 | 29.87 | 6.13% | -0.10%↓ |
| Laurus Labs Ltd. | Healthcare | 1,50,000 | 29.7 | 6.09% | 0.43%↑ |
| Lupin Ltd. | Healthcare | 1,39,000 | 28.22 | 5.79% | -0.20%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 31,500 | 25.72 | 5.28% | -0.16%↓ |
| Fortis Healthcare Ltd. | Healthcare | 2,52,000 | 19.4 | 3.98% | -0.52%↓ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 85,000 | 16.89 | 3.47% | 0.23%↑ |
| Mankind Pharma Ltd. | Healthcare | 65,000 | 16.27 | 3.34% | 0.24%↑ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 65,000 | 15.18 | 3.11% | -0.31%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 90,000 | 15.05 | 3.09% | 0.04%↑ |
| Astrazeneca Pharma India Ltd. | Healthcare | 22,000 | 13.61 | 2.79% | -0.77%↓ |
| Abbott India Ltd. | Healthcare | 4,500 | 12.21 | 2.50% | 0.21%↑ |
| Emcure Pharmaceuticals Ltd. | Healthcare | 60,000 | 11.66 | 2.39% | 0.01%↑ |
| Acutaas Chemicals Ltd. | Healthcare | 35,000 | 11.48 | 2.36% | 0.12%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 94,000 | 10.92 | 2.24% | 0.09%↑ |
| Max Financial Services Ltd. | Financial | 78,498 | 10.78 | 2.21% | -0.22%↓ |
| Aster DM Quality Care Ltd. | Healthcare | 1,50,000 | 10.46 | 2.15% | -0.08%↓ |
| Concord Biotech Ltd. | Healthcare | 75,000 | 10.3 | 2.11% | -0.03%↓ |
| Sector | 30 Sep 2026 | 31 Aug 2026 | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 93.48% | 95.02% | 92.92% | 91.07% | 88.60% | 88.41% |
| Financial | 2.21% | 2.43% | 2.27% | 2.25% | 1.22% | 1.05% |
| Services | 0.90% | 0.85% | 1.42% | 1.52% | 1.54% | 1.56% |
| Insurance | 0.47% | 0.48% | - | 3.19% | 6.05% | 6.24% |
25.6 / 100
Weighted average Value score is 25.6. This indicates that portfolio is relatively reasonably valued using composite of value measures.
64.3 / 100
Weighted average Price Momentum score is 64.3. This indicates that portfolio has average momentum using composite of momentum measures.
81.7 / 100
Weighted average Quality score is 81.7. This indicates that portfolio has high quality using composite of quality measures.
64.7 / 100
Weighted average QVM score is 64.7. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
